Swaminathan, M., Jain, N., Lovell, A., Dinh, A., Ferrajoli, A., Burger, J., Yilmaz, M., Kadia, T., Masarova, L., Valero, Y. A., Bose, P., Ravandi, F., Sasaki, K., Qiao, W., Li, Z., Garg, N., Keating, M., Wierda, W. (2025). Target dose delivery comparison: Ibrutinib + venetoclax vs. acalabrutinib + venetoclax in treatment-Naïve CLL patients in prospective clinical trials. Blood. https://doi.org/10.1182/blood-2025-5687